日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Comparison of short- and long-term outcomes between transcatheter and surgical aortic valve replacement for bicuspid aortic valve stenosis: a systematic review and meta-analysis

经导管与外科主动脉瓣置换术治疗二叶式主动脉瓣狭窄的短期和长期疗效比较：系统评价和荟萃分析

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000003377
Liu, Junning; Wei, Duoliang; Wu, Qi; Tang, Chao; Wang, Jiao; Lei, Wenqian; Wang, Yongjie; Liu, Shiqiang; Li, Peidong; Wan, Juyi
发表日期：2026
文献求助 收藏

Comparison of short-and long-term outcomes between endovascular and open repair for descending thoracic aortic aneurysm: a systematic review and meta-analysis

比较血管内修复术和开放手术治疗降主动脉瘤的短期和长期疗效：系统评价和荟萃分析

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000002230
Liu, Junning; Gou, Dan; Xu, Kanglin; Lu, Ziao; Li, Peidong; Lei, Yong; Wang, Yongjie; Yang, Yuting; Liu, Shiqiang; Zhu, Guiying
心血管
动脉瘤
发表日期：2025
文献求助 收藏

Efficacy and prognostic impact of preoperative risk factors for salvage liver transplantation and repeat hepatectomy in patients with early-stage recurrent hepatocellular carcinoma: a propensity score-matched analysis

早期复发性肝细胞癌患者术前危险因素对挽救性肝移植和再次肝切除术疗效及预后影响的倾向评分匹配分析

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1547054
Yang, Linfeng; Huang, Yang; Deng, Dawei; Liu, Junning; Xu, Liangliang; Yi, Pengsheng
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

miR-944 inhibits malignant progression of bladder cancer through ATIC/AKT/FOXO3 A axis mediated by SHMT1.

miR-944 通过 SHMT1 介导的 ATIC/AKT/FOXO3 A 轴抑制膀胱癌的恶性进展

期刊:in Vitro Cellular & Developmental Biology-Animal
影响因子:1.7
doi:10.1007/s11626-025-01050-1
Liu Zhiming, Chen Zhao, Yang Haibei, Liu Junning, Cui Maorong, Wang Weisheng
肿瘤
发表日期：2025
文献求助 收藏

Effect of sivelestat on postoperative outcomes in patients with acute type A aortic dissection and hypoxemia: a retrospective analysis

西维司他治疗急性A型主动脉夹层合并低氧血症患者术后结局的影响：一项回顾性分析

期刊:American Journal of Cardiovascular Disease
影响因子:
doi:10.62347/GXHN5984
Lei, Yong; Zhu, Guiying; Li, Peidong; Lu, Ziao; Xu, Kanglin; Liu, Junning
发表日期：2025
文献求助 收藏

Lenvatinib in combination with transarterial chemoembolization vs. sorafenib in combination with transarterial chemoembolization for unresectable hepatocellular carcinoma: A network meta‑analysis

乐伐替尼联合经动脉化疗栓塞术与索拉非尼联合经动脉化疗栓塞术治疗不可切除肝细胞癌：一项网络荟萃分析

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2024.14480
Li, Yong; Liu, Xingyu; Liu, Junning; Yang, Linfeng; Wei, Song; Li, Jijiang; Gan, Huixin; Ma, Ting; Yi, Pengsheng
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Efficacy and safety of transarterial chemoembolization plus lenvatinib with or without programmed death-1 inhibitors in the treatment of unresectable hepatocellular carcinoma: a systematic review and meta-analysis

经动脉化疗栓塞联合乐伐替尼（有或无程序性死亡受体1抑制剂）治疗不可切除肝细胞癌的疗效和安全性：系统评价和荟萃分析

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-023-05231-x
Liu, Junning; Wei, Song; Yang, Linfeng; Yu, Jiahui; Yan, Duan; Yi, Pengsheng
信号转导
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Efficacy and safety of atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a systematic review and meta-analysis

阿特珠单抗联合贝伐珠单抗与乐伐替尼治疗不可切除肝细胞癌的疗效和安全性：系统评价和荟萃分析

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-023-05342-5
Liu, Junning; Yang, Linfeng; Wei, Song; Li, Jijiang; Yi, Pengsheng
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

A retrospective study of transarterial chemoembolization (TACE) combined with lenvatinib compared with TACE monotherapy for BCLC B2 stage hepatocellular carcinoma

一项回顾性研究比较了经动脉化疗栓塞术（TACE）联合乐伐替尼与TACE单药治疗BCLC B2期肝细胞癌的疗效

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2023.14094
Liu, Junning; Yan, Shu; Zhang, Guangnian; Yang, Linfeng; Wei, Song; Yi, Pengsheng
细胞生物学
肿瘤
肿瘤免疫
CLC
发表日期：2023
文献求助 收藏

The non-coding RNA (ncRNA)-mediated high expression of polycomb group factor 1 (PCGF1) is a prognostic biomarker and is correlated with tumor immunity infiltration in liver hepatocellular carcinoma

非编码RNA（ncRNA）介导的多梳蛋白组因子1（PCGF1）高表达是一种预后生物标志物，并且与肝细胞癌中的肿瘤免疫浸润相关。

期刊:Annals of Translational Medicine
影响因子:
doi:10.21037/atm-22-3862
Liu, Junning; Xu, Yingxun; Sun, Chengcai; Yang, Shiwei; Xie, Jian; Samant, Hrishikesh; Xin, Xuezhi
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2022
文献求助 收藏